# Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer

> **NCT07630103** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **DRUG:** Trastuzumab Rezetecan for Injection (SHR-A1811)
- **DRUG:** Trastuzumab Deruxtecan for Injection (T-DXd)

## Key facts

- **NCT ID:** NCT07630103
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2031-06
- **Final completion:** 2031-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630103, "Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07630103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*